Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA To Create Inter-Center Advertising Policy Group

Executive Summary

FDA is forming an inter-center group to oversee advertising policies for different products regulated by the agency, Acting Commissioner Lester Crawford announced at a recent National Press Club luncheon in Washington, D.C

You may also be interested in...



FDA Chief Counsel Warning Letter Review To Continue After Troy’s Departure

The FDA Office of Chief Counsel's review of warning and untitled letters has resulted in the rejection of approximately 5% of letters, outgoing Chief Counsel Daniel Troy said

FDA Cites J&J Duragesic Promotion For Using Post-Market Abuse Data

FDA has issued a warning letter to Janssen for a Duragesic promotion containing comparative data versus other pain agents on post-marketing reports of abuse

FDA Cites J&J Duragesic Promotion For Using Post-Market Abuse Data

FDA has issued a warning letter to Janssen for a Duragesic promotion containing comparative data versus other pain agents on post-marketing reports of abuse

Related Content

Topics

UsernamePublicRestriction

Register

PS044505

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel